SEC filing · 10-Q

Neogen Corp: Quarterly report

Neogen reported revenue growth and narrowing operating losses for the first quarter, though bottom-line results swung to a net loss due to the absence of prior year asset sale gains.

Filed October 7, 2026 · period ended August 31, 2026

Mixed for the company

What the numbers say

Revenue rose 6.5% to $222.8M versus the same quarter last year (1.1% down on the previous quarter); operating margin widened from -7.7% to -0.8%; diluted EPS -$0.05 versus $0.17; cash fell by $13.5M to $172M while debt fell by $19.5M.

Compared with the same period a year earlier, from the figures Neogen Corp reported to the SEC.

What happened

Total revenues increased to $222.8 from $209.2, supported by strong demand in indicator and pathogen detection products.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Neogen Corp

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.